The M184V mutation in reverse transcriptase can delay reversion of attenuated variants of simian immunodeficiency virus

被引:10
|
作者
Whitney, JB
Oliveira, M
Detorio, M
Guan, YJ
Wainberg, MA
机构
[1] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, AIDS Ctr, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada
关键词
D O I
10.1128/JVI.76.17.8958-8962.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We previously constructed a series of simian immunodeficiency virus (SIV) mutants containing deletions within a 97-nucleotide region of the SIVmac239 untranslated region or leader sequence. However, as is common with live attenuated viruses, several of the mutants exhibited a moderate propensity for reversion. Since the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase is associated with diminished fitness as well as lamivudine resistance, we introduced this substitution into several of our deletion mutants to determine its effects on viral replication and compensatory reversion. Our results indicate that M184V impaired viral fitness in pair-wise comparisons of mutants that contained or lacked this substitution. We also observed that M184V significantly impaired the potential for both compensatory mutagenesis and reversion in these mutants both in cell lines and in peripheral blood mononuclear cells.
引用
收藏
页码:8958 / 8962
页数:5
相关论文
共 50 条
  • [31] Clinical impact of the M184V mutation on switching to didanosine or maintaining lamivudine treatment in nucleoside reverse-transcriptase inhibitor-experienced patients
    Winters, MA
    Bosch, RJ
    Albrecht, MA
    Katzenstein, DA
    JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (04): : 537 - 540
  • [32] The influence of the M184V mutation in HIV-1 reverse transcriptase on the virological outcome of highly active antiretroviral therapy regimens with or without didanosine
    Sprout, M
    Pozniak, AL
    Peeters, M
    Winters, B
    Hoetelmons, R
    Graham, NM
    Gazzard, BG
    ANTIVIRAL THERAPY, 2005, 10 (02) : 357 - 361
  • [33] Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against "Nucleotide-competing Reverse Transcriptase Inhibitors"
    Ehteshami, Maryam
    Scarth, Brian J.
    Tchesnokov, Egor P.
    Dash, Chandravanu
    Le Grice, Stuart F. J.
    Hallenberger, Sabine
    Jochmans, Dirk
    Goette, Matthias
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (44) : 29904 - 29911
  • [34] The H208Y mutations in reverse transcriptase is significantly associated with NRTI-exposure, M184V and TAM1 mutation pathways
    Geretti, A. M.
    Sabin, C.
    Dunn, D.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S158 - S158
  • [35] Apricitabine Does Not Select Additional Drug Resistance Mutations in Tissue Culture in Human Immunodeficiency Virus Type 1 Variants Containing K65R, M184V, or M184V plus Thymidine Analogue Mutations
    Oliveira, Maureen
    Moisi, Daniela
    Spira, Bonnie
    Cox, Susan
    Brenner, Bluma G.
    Wainberg, Mark A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (04) : 1683 - 1685
  • [36] Reverse transcriptase mutation M184V delays the selection of thymidine-analogue mutations in children infected with subtype-C HIV-1
    Averbuch, D
    Schapiro, JM
    Engelhard, D
    Gradstein, S
    Gottesman, G
    Kedem, E
    Einhorn, M
    Grisaru-Soen, G
    Ofir, M
    Milguir, F
    Rudich, H
    Ram, D
    Grossman, Z
    ANTIVIRAL THERAPY, 2004, 9 (04) : U114 - U115
  • [37] Epidemiological and Biological Evidence for a Compensatory Effect of Connection Domain Mutation N348I on M184V in HIV-1 Reverse Transcriptase
    von Wyl, Viktor
    Ehteshami, Maryam
    Symons, Jori
    Buergisser, Philippe
    Nijhuis, Monique
    Demeter, Lisa M.
    Yerly, Sabine
    Boeni, Juerg
    Klimkait, Thomas
    Schuurman, Rob
    Ledergerber, Bruno
    Goette, Matthias
    Guenthard, Huldrych F.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (07): : 1054 - 1062
  • [38] Attenuated replication of human immunodeficiency virus type 1 with a didanosine-selected reverse transcriptase mutation
    Sharma, PL
    Crumpacker, CS
    JOURNAL OF VIROLOGY, 1997, 71 (11) : 8846 - 8851
  • [39] Diminished RNA primer usage associated with the L74V and M184V mutations in the reverse transcriptase of human immunodeficiency virus type 1 provides a possible mechanism for diminished viral replication capacity
    Diallo, K
    Marchand, B
    Wei, X
    Cellai, L
    Götte, M
    Wainberg, MA
    JOURNAL OF VIROLOGY, 2003, 77 (16) : 8621 - 8632
  • [40] Human Immunodeficiency Virus-1 Viral Load Is Elevated in Individuals With Reverse-Transcriptase Mutation M184V/I During Virological Failure of First-Line Antiretroviral Therapy and Is Associated With Compensatory Mutation L74I
    Gregson, J.
    Rhee, S. Y.
    Datir, R.
    Pillay, D.
    Perno, C. F.
    Derache, A.
    Shafer, R. S.
    Gupta, R. K.
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (07): : 1108 - 1116